Compared to Semaglutide and Tirzepatide, retatrutide's exclusive inclusion of glucagon receptor agonism alongside GIP and GLP-1 receptor agonism offers a distinct pharmacological profile. While Semaglutide is often a GLP-1 receptor agonist and Tirzepatide brings together GLP-one and GIP receptor agonism, retatrutide's triple mechanism could most likely offer broader metabolic Gains. https://antonioe432xmc0.ageeksblog.com/profile